IC
LJPC

Inscription Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Inscription Capital’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$42K – 403
2021
Q1 		$42K Hold
10,000
– – 0.01% 192
2020
Q4 		$39K Hold
10,000
– – 0.02% 180
2020
Q3 		$40K Hold
10,000
– – 0.02% 171
2020
Q2 		$43K Buy
+10,000
New +$60.9K 0.02% 140

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Inscription Capital's LJPC Position: Q2 2021 in Review

Inscription Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 10,000 shares — an estimated $42K sold.

Inscription Capital first reported a position in LJPC in Q2 2020 and held it in 4 quarters. The position peaked at $43K in Q2 2020. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Inscription Capital reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Inscription Capital sold 10,000 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $42K.
  • Inscription Capital first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 4 quarters.
  • Inscription Capital's La Jolla Pharmaceutical Company position peaked at $43K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Inscription Capital's 13F filing for Q2 2021, filed 13 Aug 2021.